Structure–activity relationships of benzimidazole-based selective inhibitors of the mitogen activated kinase-5 signaling pathway

Inhibition of EGF-mediated ERK5 phosphorylation is examined for several 1-isopropyl-4-amino-6-ether linked benzimidazole-based compounds. In a prior communication we identified a novel class of benzimidazole-based inhibitors of EGF-induced phosphorylation of ERK5. In this paper we examine the biolog...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 18; no. 22; pp. 8054 - 8060
Main Authors Flaherty, Patrick T., Chopra, Ishveen, Jain, Prashi, Monlish, Darlene, Cavanaugh, Jane
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier Ltd 15.11.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Inhibition of EGF-mediated ERK5 phosphorylation is examined for several 1-isopropyl-4-amino-6-ether linked benzimidazole-based compounds. In a prior communication we identified a novel class of benzimidazole-based inhibitors of EGF-induced phosphorylation of ERK5. In this paper we examine the biological activity of several 1-isopropyl-4-amino-6-ether linked benzimidazole-based compounds for their ability to selectively inhibit EGF-mediated ERK5 phosphorylation; potential utility of variation at the 6-position was indicated by the initial structural feature survey. Modification of EGF-induced formation of pERK1/2 and pERK5 in HEK293 cells were analyzed by Western blot analysis. Subsequent analysis of selected compounds in a high-throughput multiple kinase scan and the NCI 60-cell-line screen is presented.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:0968-0896
1464-3391
DOI:10.1016/j.bmc.2010.09.017